SELLAS Life Sciences Group (SLS) Earnings Date & Reports

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SLS is expected to report earnings to rise 42.86% to -10 cents per share on August 07

SELLAS Life Sciences Group SLS Stock Earnings Reports

Q2'25

Est.

$-0.10

Q1'25

Beat

by $0.04

Q4'24

Beat

by $0.04

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.04

The last earnings report on May 13 showed earnings per share of -7 cents, beating the estimate of -10 cents. With 2.43M shares outstanding, the current market capitalization sits at 160.64M.

View a ticker or compare two or three

Compare

SLS